Mark Ogden, Gab Marcotti and Bill Connelly offer their best ideas for how to solve the Champions League's woes.

It’s déjà vu all over again. Just as the kidney disease space becomes increasingly competitive, Novartis has found itself intending to turn a statistical miss into a regulatory win. | It’s déjà vu all ...

The JEE Main 2026 Session 1 results reveal that several candidates scored 100 percentile, securing top ranks across India.

A total of 340 biopsy-confirmed IgAN patients were randomised to daily oral Vanrafia or a placebo for approximately 132 weeks.

ROYAL OAK, MI, UNITED STATES, February 2, 2026 /EINPresswire.com/ -- February can be one of the quietest — and hardest ...

Bridgebio Pharma Inc. disclosed positive top-line results from Propel 3, the global phase III pivotal study of oral infigratinib in children with achondroplasia. Change from baseline in annualized ...

Infigratinib is an investigational oral therapy designed to directly inhibit FGFR3 protein phosphorylation, addressing the underlying cause of achondroplasia.

During the programme, the battery-electric ALIA CX300 completed more than 100 flights, flew 13,000 kilometres, and visited 12 ...

Delve into the details of vertical power delivery and how it surmounts the limits of traditional lateral power when it comes to supporting secondary power rails.

The 2025-26 edition of the Champions League will be back next week when the 16 teams involved in the playoffs will take the ...

Hair shedding is when hair falls out, while hair loss is when hair stops growing properly.

Ocular Therapeutix (OCUL) is a Strong Buy, driven by the pivotal SOL-1 Phase 3 trial for AXPAXLI™ in wet AMD, with topline ...